CASP4 and COVID-19: Finally, F3 expression was elevated in PBMCs from SARS-CoV-2-infected patients compared with healthy controls (Fig. 4r), in addition to CASP4 (Fig. 4s), confirming the procoagulant genotype associated with COVID-19.